DexCare provides a platform-as-a-service solution for managing health system capacity and demand across all lines of care.
DexCare has raised $75.0M in total funding. The most recent round was Series C. The last funding was announced in June 2023.
DexCare's investors include Define Ventures, ICONIQ Growth, Frist Cressey Ventures, Transformation Capital, SpringRock Ventures.
DexCare is headquartered in Seattle, United States.
DexCare provides a platform-as-a-service solution for managing health system capacity and demand across all lines of care.
DexCare is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DexCare — Funding & Investors." VCBacked, June 21, 2023, https://www.vcbacked.co/company/dexcare. Accessed September 29, 2026.
VCBacked. (2023). DexCare — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/dexcare
{{cite web |title=DexCare — Funding & Investors |url=https://www.vcbacked.co/company/dexcare |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated